ArticleDer Nervenarzt2026
[Digital health applications and adherence in depression: a qualitative study from the perspective of healthcare providers].
Article in Der Nervenarzt, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundShortages of healthcare professionals and the rising prevalence of depressive disorders are creating gaps in care. When used correctly and consistently, digital health applications (DiGA) can help bridge these gaps. This study examines, from the perspective of healthcare providers, criteria for DiGA selection, their integration into therapy and the promotion of patient adherence.
methodsFor this qualitative study eight semi-structured expert interviews were conducted with psychiatrists, psychotherapists and general practitioners in and around Osnabrück, Germany. The interviews were analyzed using Mayring's qualitative content analysis.
resultsRespondents primarily use DiGA as adjunctive therapy or to bridge waiting periods. They seem particularly suitable for patients with mild symptoms, technical skills and good self-organization. Monitoring progress and integrating DiGA into therapeutic routines support continued use. Providers are only partially aware of their influence on adherence. Most respondents reported limited knowledge of the app content and a lack of confidence in the technology.
conclusionAlthough the effectiveness of DiGA is proven and the role of medical or therapeutic support in promoting adherence is recognized, insufficient information, a lack of transparency regarding app content and the absence of best practices are hindrances to practical implementation. To realize the full potential of DiGA providers should be supported with product-neutral, quality-assured information and practical guidance for integration into therapy.
Indexed as
Identifiers
42373767What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.